Biotechnology company developing Bionic Biologics™, a synthetic therapeutic modality that combines AI-designed peptides with precision polymer chemistry to create cell-permeable molecules targeting intracellular protein-protein interactions
Biotechnology company developing Bionic Biologics™, a synthetic therapeutic modality that combines AI-designed peptides with precision polymer chemistry to create cell-permeable molecules targeting intracellular protein-protein interactions. Its platform aims to disrupt or degrade disease-causing proteins for cancer, neurodegenerative diseases, rare disorders, and other conditions.